SCHEMBL16554186

SCHEMBL16554186

O=C(Nc1nc2c(O)cccc2s1)c1c(F)ccc(O)c1F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.63
HSD17B2 P37059 3/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2B6 P20813 1/20 0.63
CYP2C19 P33261 1/20 0.63
DYRK1A Q13627 1/20 0.59
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
RET P07949 1/20 0.49
FLT1 P17948 1/20 0.49
KDR P35968 1/20 0.49
MAPK14 Q16539 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16554188 0.82 HSD17B1 (0.65) HSD17B1HSD17B2CYP3A4CYP2D6CYP2C9
SCHEMBL29964 0.77 HSD17B1 (1.00) HSD17B1HSD17B2CYP3A4CYP2D6CYP2C9
SCHEMBL30961698 0.76 CASP3 (0.57) CASP3SENP8SENP7SENP6NPC1
SCHEMBL1040815 0.74 DYRK1A (1.00) CYP3A4CYP2C9CYP2C19DYRK1ANPC1
SCHEMBL30961692 0.74 DYRK1A (0.48) HSD17B1HSD17B2CYP3A4CYP2D6CYP2C9
SCHEMBL17770407 0.73 CASP3 (0.57) CASP3SENP8SENP7SENP6NPC1
SCHEMBL30961704 0.72 NPC1 (0.59) CASP3SENP8SENP7SENP6NPC1
SCHEMBL12988490 0.71 DYRK1A (0.72) DYRK1ANPC1RAB9AMEN1KMT2A
SCHEMBL30961702 0.70 CASP3 (0.45) HSD17B1HSD17B2CYP3A4CYP2D6CYP2C9
SCHEMBL27192229 0.70 CASP3 (0.45) HSD17B1HSD17B2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041470-A1 METHODS AND COMPOSITIONS FOR SELECTIVE AND TARGETED CANCER THERAPY Board Of Regents Of the University Of Texas System (US) 2016-07-13 EP disclosed
WO-2015035051-A1 METHODS AND COMPOSITIONS FOR SELECTIVE AND TARGETED CANCER THERAPY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-03-12 WO disclosed